ocd research

Podcast: A Potential New Treatment for OCD Offers New Hope

The podcast below is from Cutting Edge Cast From Russo’s Partners in New York. Listen to an interview with Dr. Jon Grant, Principal Investigator of CNS (Computational Neuroscience) at the University of Chicago discussing Biohaven Pharmaceutical’s investigative drug BHV 4157 and how it could offer new hope to people who suffer from OCD.

Find out more about the OCD Study and see if you qualify.